Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Arrhythmia Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Arrhythmia Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medication 1.4.3 Cardioversion 1.4.4 Catheter Ablation 1.4.5 Pacemaker 1.4.6 ICD 1.5 Market by Application 1.5.1 Global Arrhythmia Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Arrhythmia Treatment Market Perspective (2015-2026) 2.2 Arrhythmia Treatment Growth Trends by Regions 2.2.1 Arrhythmia Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Arrhythmia Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Arrhythmia Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Arrhythmia Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Arrhythmia Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Arrhythmia Treatment Players by Market Size 3.1.1 Global Top Arrhythmia Treatment Players by Revenue (2015-2020) 3.1.2 Global Arrhythmia Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Arrhythmia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Arrhythmia Treatment Market Concentration Ratio 3.2.1 Global Arrhythmia Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Arrhythmia Treatment Revenue in 2019 3.3 Arrhythmia Treatment Key Players Head office and Area Served 3.4 Key Players Arrhythmia Treatment Product Solution and Service 3.5 Date of Enter into Arrhythmia Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Arrhythmia Treatment Historic Market Size by Type (2015-2020) 4.2 Global Arrhythmia Treatment Forecasted Market Size by Type (2021-2026) 5 Arrhythmia Treatment Breakdown Data by Application (2015-2026) 5.1 Global Arrhythmia Treatment Market Size by Application (2015-2020) 5.2 Global Arrhythmia Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Arrhythmia Treatment Market Size (2015-2020) 6.2 Arrhythmia Treatment Key Players in North America (2019-2020) 6.3 North America Arrhythmia Treatment Market Size by Type (2015-2020) 6.4 North America Arrhythmia Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Arrhythmia Treatment Market Size (2015-2020) 7.2 Arrhythmia Treatment Key Players in Europe (2019-2020) 7.3 Europe Arrhythmia Treatment Market Size by Type (2015-2020) 7.4 Europe Arrhythmia Treatment Market Size by Application (2015-2020) 8 China 8.1 China Arrhythmia Treatment Market Size (2015-2020) 8.2 Arrhythmia Treatment Key Players in China (2019-2020) 8.3 China Arrhythmia Treatment Market Size by Type (2015-2020) 8.4 China Arrhythmia Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Arrhythmia Treatment Market Size (2015-2020) 9.2 Arrhythmia Treatment Key Players in Japan (2019-2020) 9.3 Japan Arrhythmia Treatment Market Size by Type (2015-2020) 9.4 Japan Arrhythmia Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Arrhythmia Treatment Market Size (2015-2020) 10.2 Arrhythmia Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Arrhythmia Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Arrhythmia Treatment Market Size by Application (2015-2020) 11 India 11.1 India Arrhythmia Treatment Market Size (2015-2020) 11.2 Arrhythmia Treatment Key Players in India (2019-2020) 11.3 India Arrhythmia Treatment Market Size by Type (2015-2020) 11.4 India Arrhythmia Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Arrhythmia Treatment Market Size (2015-2020) 12.2 Arrhythmia Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Arrhythmia Treatment Market Size by Type (2015-2020) 12.4 Central & South America Arrhythmia Treatment Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Boston Scientific 13.1.1 Boston Scientific Company Details 13.1.2 Boston Scientific Business Overview and Its Total Revenue 13.1.3 Boston Scientific Arrhythmia Treatment Introduction 13.1.4 Boston Scientific Revenue in Arrhythmia Treatment Business (2015-2020)) 13.1.5 Boston Scientific Recent Development 13.2 Medtronic 13.2.1 Medtronic Company Details 13.2.2 Medtronic Business Overview and Its Total Revenue 13.2.3 Medtronic Arrhythmia Treatment Introduction 13.2.4 Medtronic Revenue in Arrhythmia Treatment Business (2015-2020) 13.2.5 Medtronic Recent Development 13.3 St. Jude Medical 13.3.1 St. Jude Medical Company Details 13.3.2 St. Jude Medical Business Overview and Its Total Revenue 13.3.3 St. Jude Medical Arrhythmia Treatment Introduction 13.3.4 St. Jude Medical Revenue in Arrhythmia Treatment Business (2015-2020) 13.3.5 St. Jude Medical Recent Development 13.4 Mylan 13.4.1 Mylan Company Details 13.4.2 Mylan Business Overview and Its Total Revenue 13.4.3 Mylan Arrhythmia Treatment Introduction 13.4.4 Mylan Revenue in Arrhythmia Treatment Business (2015-2020) 13.4.5 Mylan Recent Development 13.5 GlaxoSmithKline 13.5.1 GlaxoSmithKline Company Details 13.5.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.5.3 GlaxoSmithKline Arrhythmia Treatment Introduction 13.5.4 GlaxoSmithKline Revenue in Arrhythmia Treatment Business (2015-2020) 13.5.5 GlaxoSmithKline Recent Development 13.6 Teva Pharmaceutical Industries 13.6.1 Teva Pharmaceutical Industries Company Details 13.6.2 Teva Pharmaceutical Industries Business Overview and Its Total Revenue 13.6.3 Teva Pharmaceutical Industries Arrhythmia Treatment Introduction 13.6.4 Teva Pharmaceutical Industries Revenue in Arrhythmia Treatment Business (2015-2020) 13.6.5 Teva Pharmaceutical Industries Recent Development 13.7 Mayne Pharma 13.7.1 Mayne Pharma Company Details 13.7.2 Mayne Pharma Business Overview and Its Total Revenue 13.7.3 Mayne Pharma Arrhythmia Treatment Introduction 13.7.4 Mayne Pharma Revenue in Arrhythmia Treatment Business (2015-2020) 13.7.5 Mayne Pharma Recent Development 13.8 Sanofi 13.8.1 Sanofi Company Details 13.8.2 Sanofi Business Overview and Its Total Revenue 13.8.3 Sanofi Arrhythmia Treatment Introduction 13.8.4 Sanofi Revenue in Arrhythmia Treatment Business (2015-2020) 13.8.5 Sanofi Recent Development 13.9 Novartis International 13.9.1 Novartis International Company Details 13.9.2 Novartis International Business Overview and Its Total Revenue 13.9.3 Novartis International Arrhythmia Treatment Introduction 13.9.4 Novartis International Revenue in Arrhythmia Treatment Business (2015-2020) 13.9.5 Novartis International Recent Development 13.10 Baxter 13.10.1 Baxter Company Details 13.10.2 Baxter Business Overview and Its Total Revenue 13.10.3 Baxter Arrhythmia Treatment Introduction 13.10.4 Baxter Revenue in Arrhythmia Treatment Business (2015-2020) 13.10.5 Baxter Recent Development 13.11 Johnson & Johnson 10.11.1 Johnson & Johnson Company Details 10.11.2 Johnson & Johnson Business Overview and Its Total Revenue 10.11.3 Johnson & Johnson Arrhythmia Treatment Introduction 10.11.4 Johnson & Johnson Revenue in Arrhythmia Treatment Business (2015-2020) 10.11.5 Johnson & Johnson Recent Development 13.12 Pfizer 10.12.1 Pfizer Company Details 10.12.2 Pfizer Business Overview and Its Total Revenue 10.12.3 Pfizer Arrhythmia Treatment Introduction 10.12.4 Pfizer Revenue in Arrhythmia Treatment Business (2015-2020) 10.12.5 Pfizer Recent Development 13.13 Sawai Pharmaceutical 10.13.1 Sawai Pharmaceutical Company Details 10.13.2 Sawai Pharmaceutical Business Overview and Its Total Revenue 10.13.3 Sawai Pharmaceutical Arrhythmia Treatment Introduction 10.13.4 Sawai Pharmaceutical Revenue in Arrhythmia Treatment Business (2015-2020) 10.13.5 Sawai Pharmaceutical Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Arrhythmia Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Arrhythmia Treatment Revenue Table 3. Ranking of Global Top Arrhythmia Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Arrhythmia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medication Table 6. Key Players of Cardioversion Table 7. Key Players of Catheter Ablation Table 8. Key Players of Pacemaker Table 9. Key Players of ICD Table 10. Global Arrhythmia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Arrhythmia Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Arrhythmia Treatment Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Arrhythmia Treatment Market Share by Regions (2015-2020) Table 14. Global Arrhythmia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Arrhythmia Treatment Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Arrhythmia Treatment Market Growth Strategy Table 20. Main Points Interviewed from Key Arrhythmia Treatment Players Table 21. Global Arrhythmia Treatment Revenue by Players (2015-2020) (Million US$) Table 22. Global Arrhythmia Treatment Market Share by Players (2015-2020) Table 23. Global Top Arrhythmia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arrhythmia Treatment as of 2019) Table 24. Global Arrhythmia Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Arrhythmia Treatment Product Solution and Service Table 27. Date of Enter into Arrhythmia Treatment Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 30. Global Arrhythmia Treatment Market Size Share by Type (2015-2020) Table 31. Global Arrhythmia Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Arrhythmia Treatment Market Size Share by Application (2015-2020) Table 33. Global Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 34. Global Arrhythmia Treatment Market Size Share by Application (2021-2026) Table 35. North America Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 36. North America Key Players Arrhythmia Treatment Market Share (2019-2020) Table 37. North America Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 38. North America Arrhythmia Treatment Market Share by Type (2015-2020) Table 39. North America Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 40. North America Arrhythmia Treatment Market Share by Application (2015-2020) Table 41. Europe Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 42. Europe Key Players Arrhythmia Treatment Market Share (2019-2020) Table 43. Europe Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 44. Europe Arrhythmia Treatment Market Share by Type (2015-2020) Table 45. Europe Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 46. Europe Arrhythmia Treatment Market Share by Application (2015-2020) Table 47. China Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 48. China Key Players Arrhythmia Treatment Market Share (2019-2020) Table 49. China Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 50. China Arrhythmia Treatment Market Share by Type (2015-2020) Table 51. China Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 52. China Arrhythmia Treatment Market Share by Application (2015-2020) Table 53. Japan Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 54. Japan Key Players Arrhythmia Treatment Market Share (2019-2020) Table 55. Japan Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 56. Japan Arrhythmia Treatment Market Share by Type (2015-2020) Table 57. Japan Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 58. Japan Arrhythmia Treatment Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players Arrhythmia Treatment Market Share (2019-2020) Table 61. Southeast Asia Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia Arrhythmia Treatment Market Share by Type (2015-2020) Table 63. Southeast Asia Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia Arrhythmia Treatment Market Share by Application (2015-2020) Table 65. India Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 66. India Key Players Arrhythmia Treatment Market Share (2019-2020) Table 67. India Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 68. India Arrhythmia Treatment Market Share by Type (2015-2020) Table 69. India Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 70. India Arrhythmia Treatment Market Share by Application (2015-2020) Table 71. Central & South America Key Players Arrhythmia Treatment Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players Arrhythmia Treatment Market Share (2019-2020) Table 73. Central & South America Arrhythmia Treatment Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America Arrhythmia Treatment Market Share by Type (2015-2020) Table 75. Central & South America Arrhythmia Treatment Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America Arrhythmia Treatment Market Share by Application (2015-2020) Table 77. Boston Scientific Company Details Table 78. Boston Scientific Business Overview Table 79. Boston Scientific Product Table 80. Boston Scientific Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 81. Boston Scientific Recent Development Table 82. Medtronic Company Details Table 83. Medtronic Business Overview Table 84. Medtronic Product Table 85. Medtronic Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 86. Medtronic Recent Development Table 87. St. Jude Medical Company Details Table 88. St. Jude Medical Business Overview Table 89. St. Jude Medical Product Table 90. St. Jude Medical Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 91. St. Jude Medical Recent Development Table 92. Mylan Company Details Table 93. Mylan Business Overview Table 94. Mylan Product Table 95. Mylan Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 96. Mylan Recent Development Table 97. GlaxoSmithKline Company Details Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Product Table 100. GlaxoSmithKline Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 101. GlaxoSmithKline Recent Development Table 102. Teva Pharmaceutical Industries Company Details Table 103. Teva Pharmaceutical Industries Business Overview Table 104. Teva Pharmaceutical Industries Product Table 105. Teva Pharmaceutical Industries Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 106. Teva Pharmaceutical Industries Recent Development Table 107. Mayne Pharma Company Details Table 108. Mayne Pharma Business Overview Table 109. Mayne Pharma Product Table 110. Mayne Pharma Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 111. Mayne Pharma Recent Development Table 112. Sanofi Business Overview Table 113. Sanofi Product Table 114. Sanofi Company Details Table 115. Sanofi Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 116. Sanofi Recent Development Table 117. Novartis International Company Details Table 118. Novartis International Business Overview Table 119. Novartis International Product Table 120. Novartis International Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 121. Novartis International Recent Development Table 122. Baxter Company Details Table 123. Baxter Business Overview Table 124. Baxter Product Table 125. Baxter Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 126. Baxter Recent Development Table 127. Johnson & Johnson Company Details Table 128. Johnson & Johnson Business Overview Table 129. Johnson & Johnson Product Table 130. Johnson & Johnson Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 131. Johnson & Johnson Recent Development Table 132. Pfizer Company Details Table 133. Pfizer Business Overview Table 134. Pfizer Product Table 135. Pfizer Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 136. Pfizer Recent Development Table 137. Sawai Pharmaceutical Company Details Table 138. Sawai Pharmaceutical Business Overview Table 139. Sawai Pharmaceutical Product Table 140. Sawai Pharmaceutical Revenue in Arrhythmia Treatment Business (2015-2020) (Million US$) Table 141. Sawai Pharmaceutical Recent Development Table 142. Research Programs/Design for This Report Table 143. Key Data Information from Secondary Sources Table 144. Key Data Information from Primary Sources List of Figures Figure 1. Global Arrhythmia Treatment Market Share by Type: 2020 VS 2026 Figure 2. Medication Features Figure 3. Cardioversion Features Figure 4. Catheter Ablation Features Figure 5. Pacemaker Features Figure 6. ICD Features Figure 7. Global Arrhythmia Treatment Market Share by Application: 2020 VS 2026 Figure 8. Hospital Case Studies Figure 9. Clinic Case Studies Figure 10. Other Case Studies Figure 11. Arrhythmia Treatment Report Years Considered Figure 12. Global Arrhythmia Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Arrhythmia Treatment Market Share by Regions: 2020 VS 2026 Figure 14. Global Arrhythmia Treatment Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Arrhythmia Treatment Market Share by Players in 2019 Figure 17. Global Top Arrhythmia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Arrhythmia Treatment as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Arrhythmia Treatment Revenue in 2019 Figure 19. North America Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America Arrhythmia Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Boston Scientific Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 28. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Medtronic Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 30. St. Jude Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. St. Jude Medical Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 32. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Mylan Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 34. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. GlaxoSmithKline Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 36. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Teva Pharmaceutical Industries Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 38. Mayne Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Mayne Pharma Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Sanofi Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 42. Novartis International Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Novartis International Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 44. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Baxter Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 46. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Johnson & Johnson Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Pfizer Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 50. Sawai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Sawai Pharmaceutical Revenue Growth Rate in Arrhythmia Treatment Business (2015-2020) Figure 52. Bottom-up and Top-down Approaches for This Report Figure 53. Data Triangulation Figure 54. Key Executives Interviewed

Boston Scientific Medtronic St. Jude Medical Mylan GlaxoSmithKline Teva Pharmaceutical Industries Mayne Pharma Sanofi Novartis International Baxter Johnson & Johnson Pfizer Sawai Pharmaceutical